SRx Health Solutions, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by SRx Health Solutions, Inc. (SRXH) on February 9, 2026, reporting events occurring on February 9 and February 11, 2026. The Company is a Delaware corporation with principal executive offices in Palm Beach, Florida, and its common stock trades on the NYSE American.
Key Financial Metrics
The filing details a specific capital transaction rather than periodic operating results. The Company redeemed all issued and outstanding shares of its Series A Convertible Preferred Stock.
- Shares Redeemed: 17,418 shares of Series A Convertible Preferred Stock.
- Total Redemption Price: Approximately $21,772,500.00.
- Operating Metrics: The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the complete elimination of the Company's Series A Convertible Preferred Stock from its capital structure. On February 9, 2026, the Company notified holders of its intent to redeem the stock pursuant to Section 9 of the Preferred Stock Certificate of Designations. The redemption was executed on February 11, 2026.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the execution of the redemption. The transaction was disclosed under Regulation FD (Item 7.01) and a press release was issued on February 11, 2026.
Investor Verification Checklist
- Verify the impact of the $21.77 million cash outflow on the Company's current liquidity position.
- Confirm the removal of the Series A Convertible Preferred Stock from the Company's balance sheet.
- Review the attached press release (Exhibit 99.1) for additional context on the redemption rationale.
- Check subsequent filings for any changes in the Company's capital structure or debt covenants resulting from this transaction.